Akira Tomiyama

This inventor holds 22 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Kotobuki Seiyaku Co. Ltd., Kotobuki Pharmaceutical Co Ltd. Active years: 1983-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Tomiyama. Retrieved from https://idiyas.com/inventor/akira-tomiyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22

% Patents Active = 90.9

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 127(Granted Patents)

Location History:

Hanishina, JP (1991)
Togura, JP (1983 - 1993)
Sakaki, JP (1990 - 1993)
Nagano, JP (1989 - 1995)
Nagano-ken, JP (1998 - 1999)
Sakaki-machi, JP (2000 - 2001)
Hanishina-gun, JP (1996 - 2002)
Hanisina-gun, JP (2003)

Company Filing History:

17 out of 23

Kotobuki Seiyaku Co. Ltd.

patents

5 out of 27

Kotobuki Pharmaceutical Co Ltd

patents

Years Active: 1983-2003

Loading Chart...

Areas of Expertise:

C-Glycosides

Antidiabetic Agents

Cycloheptimidazole Derivatives

Benzofuran

Benzothiophene

Cyclic Guanidine

Azulene Derivatives

Carboxylic Acid Derivatives

Daimine Derivatives

3-Substituted Compounds

Prostaglandins

Anti-Hyperuricemia

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6627611 - C-glycosides and preparation of thereof as antidiabetic agents (2003-09-30),

2. 6414001 - Ether and amide compounds preparation thereof composition containing same and use thereof as antidiadetics (2002-07-02),

3. 6316634 - Method for preparing cycloheptimidazoles (2001-11-13),

4. 6278027 - 3-Substituted-2-halocycloheptenone compounds and a method for manufacturing same (2001-08-21),

5. 6124460 - Isoquinuclidine derivatives, method of manufacturing the same and (2000-09-26),

6. 5990158 - Carboxylic acid derivatives, method of manufacturing the same and (1999-11-23),

7. 5843999 - 2-phenylazulene derivatives and a manufacturing method of these compounds (1998-12-01),

8. 5527815 - Carboxymethylidenecycloheptimidazole derivatives, method of (1996-06-18),

9. 5409947 - Cycloheptimidazole derivatives, method of manufacturing the same and (1995-04-25),

10. 5274000 - Benzofuran and benzothiophene derivatives, anti-hyperuricemia agents (1993-12-28),

11. 5240944 - Cyclic guanidine derivatives, anti-ulceratives and method of (1993-08-31),

12. 5175184 - Benzothiophene derivatives and antihyperuricemia thereof (1992-12-29),

13. 5081152 - Azulene derivatives as thromboxane A.sub.2 and prostaglandin (1992-01-14),

14. 5008282 - Cyclic guanidine derivatives, anti-ulceratives and methods of (1991-04-16),

15. 5004750 - Benzofuran and benzothoiphene derivatives, of tetrazole and (1991-04-02),

Title: Akira Tomiyama: A Pioneer in Antidiabetic Innovation

Introduction

Akira Tomiyama, based in Sakaki, Japan, is a distinguished inventor known for his significant contributions to the field of medicinal chemistry. With a remarkable total of 22 patents to his name, he has made substantial advancements in antidiabetic agents, showcasing his expertise and dedication to innovation.

Latest Patents

Among his latest patents, Tomiyama has developed novel C-glycosides and methods for their preparation as antidiabetic agents. Additionally, he has worked on the preparation of ether and amide compounds, along with compositions containing these substances, and their application as antidiabetic treatments. These innovations reflect his commitment to addressing critical health challenges through scientific research.

Career Highlights

Throughout his career, Akira Tomiyama has collaborated with renowned companies such as Kotobuki Seiyaku Co., Ltd. and Kotobuki Pharmaceutical Co., Ltd. His work with these organizations has enabled him to translate innovative concepts into practical solutions in the pharmaceutical industry, particularly in diabetes care.

Collaborations

Collaboration has been an integral part of Akira Tomiyama's journey as an inventor. He has notably worked alongside esteemed coworkers, including Tsuyoshi Tomiyama and Naoto Ueyama. Together, they have contributed to advancements in drug formulations and therapeutic approaches, solidifying their impact in the field.

Conclusion

Akira Tomiyama's innovative spirit and his dedication to developing antidiabetic agents underscore his position as a key figure in the realm of pharmaceuticals. With a strong portfolio of patents and fruitful collaborations, he continues to inspire future generations of inventors and researchers seeking to make a difference in healthcare.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]